Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women.
Kadalayil L, Khan S, Nevanlinna H, Fasching PA, Couch FJ, Hopper JL, Liu J, Maishman T, Durcan L, Gerty S, et al. Nat Commun. 2017 Nov 21; 8(1):1632. Epub 2017 Nov 21.